Incidence and prevalence of non-melanoma skin cancer in Australia: A systematic review

被引:150
|
作者
Perera, Eshini [1 ,4 ]
Gnaneswaran, Neiraja [1 ]
Staines, Carolyn [3 ]
Win, Aung Ko [2 ]
Sinclair, Rod [1 ,4 ]
机构
[1] Univ Melbourne, Dept Med, Sch Populat & Global Hlth, Melbourne, Vic 3010, Australia
[2] Univ Melbourne, Sch Populat & Global Hlth, Ctr Epidemiol & Biostat, Melbourne, Vic 3010, Australia
[3] Canc Council Victoria, Melbourne, Vic, Australia
[4] Sinclair Dermatol, Melbourne, Vic, Australia
关键词
basal cell carcinoma; epidemiology; incidence; keratinocyte cancer; non-melanoma skin cancer; non melanoma; nonmelanoma; prevalence; squamous cell carcinoma; MEDICARE CLAIMS DATA; WESTERN-AUSTRALIA; NATIONAL-SURVEY; POPULATION; QUEENSLAND; TRENDS; RATES; CARCINOMA; GERALDTON;
D O I
10.1111/ajd.12282
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Non-melanoma skin cancer (NMSC), including basal cell carcinoma (BCC) and squamous cell carcinoma (SCC), is the most common cancer occurring in people with fair skin. Australia has been reported to have the highest incidence of NMSC in the world. Using a systematic search of the literature in EMBASE and Medline, we identified 21 studies that investigated the incidence or prevalence of NMSC in Australia. Studies published between 1948 and 2011 were identified and included in the analysis. There were six studies that were conducted on national level, two at state level and 13 at the regional level. Overall, the incidence of NMSC had steadily increased over calendar-years in Australia. The incidence of NMSC per 100 000 person-years was estimated to be 555 in 1985; 977 in 1990; 1109 in 1995; 1170 in 2002 and 2448 in 2011. The incidence was higher for men than women and higher for BCC than SCC. Incidence varied across the states of Australia, with the highest in Queensland. The prevalence of NMSC was estimated to be 2% in Australia in 2002. The incidence and prevalence of NMSC still need to be accurately established at both national and state levels to determine the costs and burden of the disease on the public health system in Australia.
引用
收藏
页码:258 / 267
页数:10
相关论文
共 50 条
  • [41] MicroRNA in non-melanoma skin cancer
    Sand, Michael
    Sand, Daniel
    Altmeyer, Peter
    Bechara, Falk G.
    CANCER BIOMARKERS, 2012, 11 (06) : 253 - 257
  • [42] Photoimmunology of non-melanoma skin cancer
    Streilein, JW
    CANCER SURVEYS, 1996, 26 : 207 - 217
  • [43] Cetuximab in non-melanoma skin cancer
    Wollina, Uwe
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2012, 12 (07) : 949 - 956
  • [44] Review: the reemergence of brachytherapy as treatment for non-melanoma skin cancer
    Ota, Koji
    Adar, Tony
    Dover, Laura
    Khachemoune, Amor
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2018, 29 (02) : 170 - 175
  • [45] The management of non-melanoma skin cancer
    Campbell, FA
    Gupta, G
    HOSPITAL MEDICINE, 2005, 66 (05): : 288 - 293
  • [46] NON-MELANOMA SKIN-CANCER
    DUVIVIER, A
    PRACTITIONER, 1984, 228 (1392) : 549 - 553
  • [47] NON-MELANOMA SKIN-CANCER
    MORA, RG
    PRIMARY CARE, 1989, 16 (03): : 665 - 684
  • [48] Risk of subsequent non-melanoma skin cancers in patients with prior non-melanoma skin cancer
    Wehner, M. R.
    Linos, E.
    Parvataneni, R.
    Stuart, S. E.
    Boscardin, W. J.
    Chren, M.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2013, 133 : S93 - S93
  • [49] Immunotherapy for Non-melanoma Skin Cancer
    Sophia Z. Shalhout
    Kevin S. Emerick
    Howard L. Kaufman
    David M. Miller
    Current Oncology Reports, 2021, 23
  • [50] Welding and non-melanoma skin cancer
    Currie, CLA
    Monk, BE
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2000, 25 (01) : 28 - 29